Investing.com -- Integrum AB has shared the results of an independent study conducted by the Walter Reed National Military Medical (TASE:BLWV) Center in Bethesda, Maryland, U.S. The study provides strong evidence of the effectiveness of Integrum’s OPRA™ Implant System in treating transfemoral amputees. The findings suggest that the system offers significant functional improvements over traditional socket prostheses, demonstrating the innovation and clinical benefit of Integrum’s technology.
The study followed patients for two years and used the latest version of the OPRA™ Implant System, which was launched in 2017. The results highlighted several advantages for patients using the implant, including increased prosthetic use, improved mobility, and an enhanced quality of life. The study also showed improved outcomes compared to previously published data, such as fewer infections and complications, and a 100% implant survival rate.
Scott Flora, acting CEO of Integrum, stated, "This study confirms the safety, durability, and positive impact of the OPRA Implant System for individuals who have undergone amputation. We are honored to support the men and women who have served their country and are excited to see growing evidence supporting its role in improving mobility and overall well-being for amputees globally."
The insights from this study could encourage further adoption of the technology by U.S. healthcare providers and raise awareness of the OPRA™ Implant System among healthcare professionals and potential patients.
Dr. Jonathan Forsberg, MD, PhD, who is currently practicing at Memorial Sloan Kettering in New York, and retired from the military after 32 years of service, said, "We need high quality prospective clinical trials like this to confirm not only the benefits of transdermal bone anchored implants, but also the complication profile over the long-term. By further proving safety and effectiveness of The OPRA Implant System, we hope this growing body of evidence will encourage exponential acceptance among US insurance providers for reimbursement, making this life-changing technology more accessible to patients in need."
Dr. Benjamin K. Potter, MD, currently Chair, Department of Orthopaedic Surgery at Penn Medicine in Philadelphia, PA, and retired from the Army after over 22 years of service, commented, "We were excited to see that our results further confirmed the benefits of direct skeletal attachment for improving function and quality of life for patient with limb loss, while maintaining better than expected infection and major complication rates."
The study was recently published in Clinical Orthopaedics and Related Research (CORR) and was authored by Benjamin K. Potter, MD, Jonathan A. Forsberg, MD, PhD, LCDR Ashley B. Anderson, MD, Jason M. Souza, MD, and Julio Rivera, PhD.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.